Basis of Presentation

6 Months Ended

Jun. 30, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation

Basis of Presentation:

In the opinion of management, the accompanying unaudited condensed consolidated financial statements of Albemarle Corporation and our wholly-owned, majority-owned and controlled subsidiaries (collectively, “Albemarle,” “we,” “us,” “our” or the “Company”) contain all adjustments necessary for a fair statement, in all material respects, of our consolidated balance sheets as of June 30, 2025 and December 31, 2024, our consolidated statements of income (loss), consolidated statements of comprehensive income (loss) and consolidated statements of changes in equity for the three-month and six-month periods ended June 30, 2025 and 2024 and our condensed consolidated statements of cash flows for the six-month periods ended June 30, 2025 and 2024. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2024, as filed with the U.S. Securities and Exchange Commission (“SEC”) on February 12, 2025. The December 31, 2024 consolidated balance sheet data herein was derived from audited financial statements, but does not include all disclosures required by generally accepted accounting principles (“GAAP”) in the United States (“U.S.”). The results of operations for the three-month and six-month periods ended June 30, 2025 are not necessarily indicative of the results to be expected for the full year.

Revision of Previously Issued Financial Information

During the second quarter of 2025, the Company identified an error in classification within its condensed consolidated statements of cash flows related to the proceeds from settlement and unrealized gains or losses from foreign currency forward contracts, affecting the cash flows from operating activities section, the cash flows from investing activities section and the Net effect of foreign exchange on cash and cash equivalents line of the statements of cash flows. The identified misclassification impacted our previously filed annual financial statements for the fiscal years ended December 31, 2024, 2023 and 2022, and quarterly financial statements for each of the fiscal quarters of fiscal year 2024 and the first fiscal quarter of fiscal year 2025 (collectively, the “Prior Financial Statements”). In addition, the Company made adjustments to correct for other previously identified immaterial errors. The Company assessed the materiality of the error in accordance with the SEC’s Staff Accounting Bulletin (“SAB”) No. 99 and SAB No. 108 and determined that the resulting misclassification was not material in any of the Prior Financial Statements, individually or in the aggregate. This revision had no impact on the consolidated balance sheets, consolidated statements of income (loss), consolidated statements of comprehensive income (loss), or consolidated statements of changes in equity of the Prior Financial Statements or notes thereto.

A summary of the revisions to the Prior Financial Statements are shown below (in thousands):

	Three Months Ended March 31, 2025
	As Reported		Revision		As Revised
Noncurrent liability changes and other, net	$	357,146	$	1,824	$	358,970
Net cash provided by operating activities	545,383		1,824		547,207
Proceeds from settlement of foreign currency forward contracts, net	$	—	$	50,245	$	50,245
Net cash used in investing activities	(179,303)		50,245		(129,058)
Net effect of foreign exchange on cash and cash equivalents	$	80,207	$	(52,069)	$	28,138

	Year Ended December 31, 2024
	As Reported		Revision		As Revised
Decrease (increase) in inventories	$	1,560,450	$	(5,261)	$	1,555,189
Other, net	(107,104)		(8,931)		(116,035)
Net cash provided by operating activities	702,068		(14,192)		687,876
Capital expenditures	$	(1,685,790)	$	5,261	$	(1,680,529)
Payments for settlement of foreign currency forward contracts, net	—		(15,595)		(15,595)
Net cash used in investing activities	(1,574,438)		(10,334)		(1,584,772)
Net effect of foreign exchange on cash and cash equivalents	$	(67,035)	$	24,526	$	(42,509)

	Nine Months Ended September 30, 2024
	As Reported		Revision		As Revised
Working capital changes	$	823,194	$	7,657	$	830,851
Other, net	(17,415)		(16,796)		(34,211)
Net cash provided by operating activities	701,394		(9,139)		692,255
Capital expenditures	$	(1,330,062)	$	(7,657)	$	(1,337,719)
Payments for settlement of foreign currency forward contracts, net	—		(1,956)		(1,956)
Net cash provided by (used in) investing activities	(1,246,628)		(9,613)		(1,256,241)
Net effect of foreign exchange on cash and cash equivalents	$	(14,763)	$	18,752	$	3,989

	Six Months Ended June 30, 2024
	As Reported		Revision		As Revised
Working capital changes	$	460,937	$	7,657	$	468,594
Other, net	(118,711)		(3,355)		(122,066)
Net cash provided by operating activities	460,846		4,302		465,148
Capital expenditures	$	(1,026,936)	$	(7,657)	$	(1,034,593)
Proceeds from settlement of foreign currency forward contract, net	—		12,991		12,991
Net cash provided by (used in) investing activities	(944,506)		5,334		(939,172)
Net effect of foreign exchange on cash and cash equivalents	$	(20,595)	$	(9,636)	$	(30,231)

	Three Months Ended March 31, 2024
	As Reported		Revision		As Revised
Working capital changes	$	(52,320)	$	3,720	$	(48,600)
Other, net	(23,076)		(4,189)		(27,265)
Net cash provided by operating activities	97,954		(469)		97,485
Capital expenditures	$	(579,322)	$	(3,720)	$	(583,042)
Proceeds from settlement of foreign currency forward contracts, net	—		18,224		18,224
Net cash provided by (used in) investing activities	(494,503)		14,504		(479,999)
Net effect of foreign exchange on cash and cash equivalents	$	5,162	$	(14,035)	$	(8,873)

	Year Ended December 31, 2023
	As Reported		Revision		As Revised
Decrease (increase) in inventories	$	(962,924)	$	5,261	$	(957,663)
Other, net	(97,275)		(3,999)		(101,274)
Net cash provided by operating activities	1,325,321		1,262		1,326,583
Capital expenditures	$	(2,149,281)	$	(5,261)	$	(2,154,542)
Proceeds from settlement of foreign currency forward contracts, net	—		221,849		221,849
Net cash used in investing activities	(2,781,160)		216,588		(2,564,572)
Net effect of foreign exchange on cash and cash equivalents	$	222,686	$	(217,850)	$	4,836

	Year Ended December 31, 2022
	As Reported		Revision		As Revised
Other, net	$	91,270	$	4,567	$	95,837
Net cash provided by operating activities	1,907,849		4,567		1,912,416
Payments for settlement of foreign currency forward contracts, net	$	—	$	(31,414)	$	(31,414)
Net cash used in investing activities	(1,422,649)		(31,414)		(1,454,063)
Net effect of foreign exchange on cash and cash equivalents	$	(37,217)	$	26,847	$	(10,370)